In a historic move, the World Health Organization has launched its inaugural clinical trial for an Ebola vaccine in the Democratic Republic of Congo. This trial aims to assess the efficacy of the Ervebo vaccine against the Bundibugyo virus amid a severe outbreak that has resulted in over 9,700 cases and 4,600 fatalities since May.
Trending
- What arriving early says about control, responsibility and stress: Psychology
- Watch: Iran shows Trump behind bars on live billboard on busy Tehran street
- ‘Disappointed? You’re not alone’: FIR filed over posters in Delhi Metro questioning govt
- 18-year-old Anahat’s historic run at Silicon Valley Open comes to an end
- ITBP Raising Day: PM Modi praises ‘Himveers’ as India-China border management remains in focus
- Engineer sues Nscale ahead of NYSE listing over wrongful termination claim
- Tumaini Trial Launch: WHO begins Ebola vaccine study in DRC; aims to protect against Bundibugyo strain
- Kerala governor Om Prakash Mathur’s ‘veg-only kitchen’ diktat on first day of assuming office sparks row
Tumaini Trial Launch: WHO begins Ebola vaccine study in DRC; aims to protect against Bundibugyo strain
By
Add A Comment